[1] |
ZHAN Shicheng, CHEN Peiqin, QIU Moqin, WEN Qiuping, ZHOU Zihan, LIN Qiuling, JIANG Yanji, ZHOU Xianguo, CAO Ji, GUO Qian, NONG Cunli, YU Hongping, LIU Yingchun.
Association of genetic variants in eukaryotic translation initiation factor 3 and risk of HBV⁃related hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 62-69.
|
[2] |
LIN Qiuling, LIU Yingchun, WEN Qiuping, ZHOU Zihan, JIANG Yanji, LIANG Xiumei, GONG Wenfeng, MA Liang, LIU Shuyan, YU Hongping.
Association between polymorphisms in miRNA binding site of BRCA1 gene and overall survival of hepatocellular carcinoma after operation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(2): 183-189.
|
[3] |
WEI Lingchun, LIAO Xiaoli, HUANG Wenfeng, LIAO Sina, LIU Zhihui, LI Yongqiang.
Association between HJURP gene polymorphism and the efficacy and adverse reactions of oxaliplatin-based chemotherapy for advanced hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(4): 447-452.
|
[4] |
XIONG Han, LIN Rui, TANG Weizhu, MENG Qinggui, ZHANG Qingyun, CHEN Yang, CHENG Jiwen.
Effect of LRP1 on the incidence of prostate cancer based on genome-wide ChinaPca data and gene expression
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(5): 387-392.
|
[5] |
XIE Xiaonan, WEN Yiyong, LING Qiongying, HUANG Wenfeng, QIN Fanghui, WANG Hongxue, ZHOU Wenxian, LU Yongkui, XIE Yu'an, XIE Weimin.
Association between RAD23B gene rs10759225 polymorphism and clinical outcomes of non-small cell lung cancer patients treated with platinum-based chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(2): 151-157.
|
[6] |
Wu Linghong,Huang Tianren,Deng Wei,Huang Zhibi,Guo Jiao,Huang Yueying.
Meta-analysis:the relationship of hepatitis B virus genotypes,subgenotypes and hepato-cellular carcinoma in China
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 365-370.
|
[7] |
Tan Baogao,Liu Biao.
The value of 3.0T MR arterial spin labeling in the diagnosis of early-stage primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 310-313.
|
[8] |
Jiang Qunxiang,Wei Feifei,Wang Hongxue,Guo Hui,Xie Yu'an.
Relationships between polymorphism in the growth hormone receptor gene and risk of hepatocellular carcinoma in families of Fusui County,Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 205-208.
|
[9] |
Yin zhenzhen,Wang Xiaoyan,Jiang Xiangjun.
Relationship between IL-17 gene polymorphism and gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(1): 50-54.
|
[10] |
Ren Ai'hua,Liao Yan,Wei Liujun,Zhao Ruiqiang,Wei Feifei,Xie Yu'an.
DDX39 single-nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma in clusters of families with liver cancer in Fusui County, Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(6): 344-348.
|
[11] |
Wei Feifei, Liao Yan, Zhao Ruiqiang, Wang Hongxue, Xie Yu'an.
ITGβ1 polymorphism and genetic susceptibility to hepatocellular carcinoma in families from the Zhuang community in Fusui County, Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(5): 273-277.
|
[12] |
Xiang Nana,Zhang Keke.
BRCA1 expression in prostate carcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(4): 217-220.
|
[13] |
Mao Sailan,He Chengcheng,Zhao Ruiqiang,Yan Lei,Huang Zheng,Xie Yu′an.
Single nucleotide polymorphism in the integrin beta1 gene and genetic susceptibility to hepatocellular carcinoma in clusters of families with liver cancer in Fusui County,Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(2): 78-82.
|
[14] |
Gao Yan,Cui Yanxin,Jiang Xiangjun.
Association of Dnmt1 single-nucleotide polymorphisms and risk of gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2015, 7(6): 394-397.
|
[15] |
CAI Zu′ai,ZHANG Wei.
Meta-analysis of the association between ERCC1 gene 19007C / T polymorphism and response of patients with epithelial ovarian cancer to platinum-based combination chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2015, 7(4): 276-281.
|